Iran (Islamic Republic of)

Last Updated 21 April 2021.

4 Vaccines Approved for Use in Iran (Islamic Republic of)

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 91 countries

  24 trials in 15 countries

  Non Replicating Viral Vector

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 62 countries

  19 trials in 6 countries

  Non Replicating Viral Vector

• Bharat Biotech
  Covaxin

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 6 countries

  5 trials in 1 country

  Inactivated

• Sinopharm (Beijing)
  BBIBP-CorV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 35 countries

  6 trials in 7 countries

  Inactivated

3 Vaccines in Clinical Trials in Iran (Islamic Republic of)

• Shifa Pharmed Industrial Co
  COVID-19 Inactivated Vaccine

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 3 trials.

  4 trials in 1 country

  Inactivated

• Razi Vaccine and Serum Research Institute
  Razi Cov Pars

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  2 trials in 1 country

  Protein Subunit

• Organization of Defensive Innovation and Research
  FAKHRAVAC (MIVAC)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 1 trials.

  1 trial in 1 country

  Inactivated